Neogen (Lansing) Overview
- Year Founded
-
1981
- Status
-
Public
- Employees
-
1,257
- Stock Symbol
-
NEOG
- Investments
-
50
- Share Price
-
$10.88
- (As of Monday Closing)
Neogen (Lansing) General Information
Description
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.
Contact Information
Website
www.neogen.comCorporate Office
- 620 Lesher Place
- Lansing, MI 48912
- United States
Corporate Office
- 620 Lesher Place
- Lansing, MI 48912
- United States
Neogen (Lansing) Stock Performance
As of 16-Nov-2026, Neogen (Lansing)’s stock price is $10.88. Its current market cap is $2.38B with 218M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $10.88 | $11.23 | $5.37 - $14.26 | $2.38B | 218M | 3.47M | -$0.25 |
Neogen (Lansing) Financials Summary
As of 31-Aug-2026, Neogen (Lansing) has a trailing 12-month revenue of $884M.
|
In Thousands, USD |
TTM 31-Aug-2026 | FY 2026 31-May-2026 | FY 2025 31-May-2025 | FY 2024 31-May-2024 |
|---|---|---|---|---|
| EV | 3,129,505 | 2,585,927 | 2,037,245 | 3,570,119 |
| Revenue | 883,991 | 870,400 | 894,700 | 924,200 |
| EBITDA | 109,992 | 170,500 | (944,800) | 173,900 |
| Net Income | (56,124) | (7,900) | (1,092,000) | (9,400) |
| Total Assets | 3,303,200 | 3,346,000 | 3,443,800 | 4,548,833 |
| Total Debt | 774,200 | 793,700 | 894,100 | 890,838 |
Neogen (Lansing) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Neogen (Lansing) Comparisons
Industry
Financing
Details
Neogen (Lansing) Competitors (5)
One of Neogen (Lansing)’s 5 competitors is Zoetis, a Corporation company based in Parsippany, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Zoetis | Corporation | Parsippany, NJ | ||||
| Phibro Animal Health | Formerly PE-Backed | Teaneck, NJ | ||||
| Virbac Nederland | Corporation | Barneveld, Netherlands | ||||
| MWI Veterinary Supply | Corporate Backed or Acquired | Boise, ID | ||||
| Virbac Österreich | Corporation | Vienna, Austria |
Neogen (Lansing) Patents
Neogen (Lansing) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025255017-A1 | Development of a novel, rapid, and quantitative method for the measurement of carry-over α-amylase content in sugar samples | Pending | 03-Jun-2024 | ||
| WO-2025217253-A1 | Neutralizing compositions and related methods | Pending | 12-Apr-2024 | ||
| WO-2025212363-A1 | Quantitative pathogen detection method | Pending | 01-Apr-2024 | ||
| WO-2025165683-A1 | Enrichment medium for gram-negative bacteria | Pending | 29-Jan-2024 | ||
| US-20250103479-A1 | Dynamic random-access memory (dram) efficiency calculation and utilization of last level cache (llc) | Active | 27-Sep-2023 | G06F12/023 |
Neogen (Lansing) Signals
Neogen (Lansing) Investments & Acquisitions (50)
Neogen (Lansing)’s most recent deal was a Merger/Acquisition with Corvium for . The deal was made on 10-Feb-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Corvium | 10-Feb-2023 | Merger/Acquisition | Business/Productivity Software | ||
| 3M (3M's Food Safety Business) | 01-Sep-2022 | Merger/Acquisition | Electronic Equipment and Instruments | ||
| Thai-Neo Biotech | 01-Jul-2022 | Merger/Acquisition | Distributors/Wholesale | ||
| Paw Print Genetics | 09-Dec-2021 | Merger/Acquisition | Other Services (B2C Non-Financial) | ||
| Abbott Analytical | 30-Nov-2021 | Merger/Acquisition | Laboratory Services (Healthcare) |
Neogen (Lansing) ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
23.79 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Laboratory Equipment and Services
Subindustry
of 67
Rank
Percentile
Neogen (Lansing) Affiliates
Subsidiaries (7)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| CAPInnoVet | Atlanta, GA | 2014 | |
| Paw Print Genetics | Lincoln, NE | 2012 | |
| GeneSeek | Lincoln, NE | 1998 | |
| Magiar Feed | Buenos Aires, Argentina | 1991 | |
| Megazyme | Wicklow, Ireland | 1988 |
Neogen (Lansing) FAQs
-
When was Neogen (Lansing) founded?
Neogen (Lansing) was founded in 1981.
-
Where is Neogen (Lansing) headquartered?
Neogen (Lansing) is headquartered in Lansing, MI.
-
What is the size of Neogen (Lansing)?
Neogen (Lansing) has 1,257 total employees.
-
What industry is Neogen (Lansing) in?
Neogen (Lansing)’s primary industry is Other Commercial Products.
-
Is Neogen (Lansing) a private or public company?
Neogen (Lansing) is a Public company.
-
What is Neogen (Lansing)’s stock symbol?
The ticker symbol for Neogen (Lansing) is NEOG.
-
What is the current stock price of Neogen (Lansing)?
As of 16-Nov-2026 the stock price of Neogen (Lansing) is $10.88.
-
What is the current market cap of Neogen (Lansing)?
The current market capitalization of Neogen (Lansing) is $2.38B.
-
What is Neogen (Lansing)’s current revenue?
The trailing twelve month revenue for Neogen (Lansing) is $884M.
-
Who are Neogen (Lansing)’s competitors?
Zoetis, Phibro Animal Health, Virbac Nederland, MWI Veterinary Supply, and Virbac Österreich are competitors of Neogen (Lansing).
-
What is Neogen (Lansing)’s annual earnings per share (EPS)?
Neogen (Lansing)’s EPS for 12 months was -$0.25.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process